HLS Therapeutics Inc.
HLTRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20 | -$28 | -$24 | -$13 |
| Dep. & Amort. | $23 | $33 | $34 | $30 |
| Deferred Tax | $4 | -$1 | $0 | $1 |
| Stock-Based Comp. | $2 | -$1 | $3 | $2 |
| Change in WC | $1 | $5 | $2 | -$3 |
| Other Non-Cash | -$2 | $6 | $2 | -$1 |
| Operating Cash Flow | $8 | $16 | $17 | $16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$10 | -$5 |
| Net Acquisitions | -$2 | $0 | $0 | -$4 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $13 | -$0 | -$10 | $4 |
| Investing Cash Flow | $12 | -$0 | -$10 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$22 | -$9 | -$0 | -$11 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1 | -$2 | -$1 | -$0 |
| Dividends Paid | $0 | -$2 | -$5 | -$5 |
| Other Fin. Act. | -$1 | -$1 | -$0 | $5 |
| Financing Cash Flow | -$23 | -$15 | -$7 | -$11 |
| Forex Effect | -$1 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$4 | $1 | -$0 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22 | $21 | $21 | $21 |
| End Cash | $17 | $22 | $21 | $21 |
| Free Cash Flow | $8 | $16 | $7 | $12 |